Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Feb. 28, 2025	Feb. 29, 2024
Cash Flows from Operating Activities:
Net Income	$ 464,318	$ 408,606
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	140,092	126,656
Deferred income taxes	(47,012)	2,190
Stock-based compensation expense	21,494	19,457
Net (gain) on marketable securities	(5,125)	(16,496)
Net loss on sales of assets and businesses	0	2,576
Other	(635)	1,244
Changes in assets and liabilities, net of effect from purchases and sales of businesses:
Decrease in receivables	302,429	430,512
(Increase) decrease in inventory	(96,539)	55,118
(Increase) decrease in prepaid expenses and other current and long-term assets	(35,973)	30,349
Increase (decrease) in accounts payable	5,174	(83,960)
(Decrease) in accrued compensation and benefits	(82,118)	(20,049)
Increase in accrued losses	1,383	4,366
(Decrease) in other accrued liabilities	(48,476)	(19,424)
Cash Provided by Operating Activities	619,012	941,145
Cash Flows from Investing Activities:
Capital expenditures	(158,924)	(138,093)
Acquisition of businesses, net of cash acquired	(127,325)	(15,549)
Purchase of marketable securities	(77,640)	(30,591)
Proceeds from sales of marketable securities	59,460	22,130
Proceeds from sales of assets and businesses, net	0	5,749
Other	(1,236)	2,485
Cash (Used for) Investing Activities	(305,665)	(153,869)
Cash Flows from Financing Activities:
Additions to long-term and short-term debt	104,047	0
Reductions of long-term and short-term debt	(136,379)	(516,086)
Cash dividends	(190,064)	(172,601)
Repurchases of common stock	(52,499)	(37,488)
Shares of common stock returned for taxes	(17,140)	(21,949)
Payments of acquisition-related contingent consideration	(1,122)	(1,082)
Other	(1,014)	(1,586)
Cash (Used for) Financing Activities	(294,171)	(750,792)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(14,660)	(3,366)
Net Change in Cash and Cash Equivalents	4,516	33,118
Cash and Cash Equivalents at Beginning of Period	237,379	215,787
Cash and Cash Equivalents at End of Period	241,895	248,905
Cash paid during the period for:
Interest	71,931	90,770
Income Taxes, net of refunds	180,243	172,008
Supplemental Disclosures of Noncash Investing Activities:
Capital expenditures accrued within accounts payable at quarter-end	$ 14,721	$ 12,621